SITC Resource Library

Targets in Cancer IO: A Deep Dive in Enhanced CTLA-4 blockade webinar- October 5, 2022 

10-07-2022 10:14

This is the library for the enduring materials from the Targets in Cancer IO: A Deep Dive in Enhanced CTLA-4 blockade webinar that was conducted on October 5, 2022.

Moderators:

  • James P. Allison, PhD, FAIO – The University of Texas MD Anderson Cancer Center
  • Alan J. Korman, PhD, FAIO – Vir Biotechnology


Faculty:

  • Aurelien Marabelle, MD, PhD – Gustave Roussy
  • Simon J. Dovedi, PhD – AstraZeneca
  • Nick Wilson, PhD – Bristol Myers Squibb
  • Dhan Chand, PhD – Agenus

Targets for Cancer IO: A Deep Dive Series 2 is supported, in part, by educational grants from Genmab, US, Inc. Iovance Biotherapeutics, and Merck & Co., Inc. (as of 7/26/2022).




Interested in supporting this program? The SITC Development team would love to work with you. Contact Development@sitcancer.org for more information on how your organization's support can help advance cancer immunotherapy and make "cure" a reality.

Statistics
1 Favorited
218 Views
4 Files
0 Shares
157 Downloads
Attachment(s)
pdf file
New mechanistic insights for broader therapeutic potenti...   1.95 MB   1 version
Uploaded - 10-10-2022
Meeting:2022 Targets in Cancer IO: A Deep Dive in Enhanced CTLA-4 blockade; Presenter: Dhan Chand, PhD – Agenus; Date: October 5, 2022
pdf file
CTLA-4 BispecificAntibody   2.49 MB   1 version
Uploaded - 10-10-2022
Meeting:2022 Targets in Cancer IO: A Deep Dive in Enhanced CTLA-4 blockade; Presenter: Simon J. Dovedi, PhD – AstraZeneca; Date: October 5, 2022
pdf file
or Treg Depletion   3.70 MB   1 version
Uploaded - 10-10-2022
Meeting:2022 Targets in Cancer IO: A Deep Dive in Enhanced CTLA-4 blockade; Presenter: Aurelien Marabelle, MD, PhD – Gustave Roussy; Date: October 5, 2022

Related Entries and Links

No Related Resource entered.